Page 68 - HA Convention 2016 [Abstracts (Day 1)]
P. 68

HOSPITAL AUTHORITY CONVENTION 2016  Service Enhancement Presentations

                                    F4.2  Clinical Safety and Quality Service II  16:15  Room 421

                                    To Safeguard Unintentional Repetition of Drug during Transition of Care in Medication Order Entry
                                    Chan JKY, Pang JYW, Cheung NT
                                    Health Informatics Section, Information Technology and Health Informatics Division, Hospital Authority Head Office, Hong Kong

                                    Introduction

                                    There was a number of medication incidents related to unintentional repetition of drugs during transition of care. Hospital
                                    Authority Clinical Management System (HA CMS) Medication Order Entry (MOE) provided the flexibility of repetition of drugs
                                    in busy clinical environment. However, the convenience also created unintentional prescription of drugs and medication
                                    incidents.

                                    Objectives

                                    To mark discontinuation in corresponding drug item explicitly in MOE in order to avoid unintentional repetition of drugs in next
                                    consultation or transition of care.

Tuesday, 3 May                      Methodology

                                    When doctor decided to discontinue a particular drug explicitly due to whatever clinical reason, the corresponding drug item
                                    in previous prescription history was allowed to mark discontinuation in MOE. The drug item with strikethrough effect would
                                    be shown in both MOE and Electronic Patient Record (ePR) with reason of discontinuation shown. The corresponding drug
                                    item would not be allowed to repeat automatically in next consultation or during transition of care. Moreover, the discontinued
                                    drug item in all CMS printout with medication included would also be shown with strikethrough effect.

                                    Results

                                    Explicit discontinuation of medication was piloted in Kowloon East Cluster in August 2015 and further rollout in remaining
                                    six clusters in November 2015. There were t512 drug items in total marked discontinued explicitly as of 4 January 2016.
                                    Nine drug items (1.76%) were discontinued explicitly by Accident and Emergency Department; 15 drug items (2.93%) were
                                    discontinued by Community Geriatric Assessment Team; 234 drug items (45.7%) were discontinued by General Outpatient
                                    Clinic; 61 drug items (11.9%) during in-patient management while 193 drug items were managed in Specialist Outpatient
                                    Clinic. Case examples for illustration: Patient with multiple medical problems - presented with retrosternal chest pain with
                                    cardiac catheterisation done in August 2015 was managed by family physician (FM). Elantan was off and changed to ACEi
                                    by cardiologist. He explicitly discontinued Elantan which was prescribed by FM on last FM follow-up (25 June 2015) so that
                                    FM would not repeat Elantan during the next FM follow-up. Patient with percutaneous cardiac catheterisation (PCI) done
                                    and planned to have one year Clopidogrel with the whole course, Clopidogrel was marked discontinued in order to prevent
                                    unintentional repeated prescription in subsequent follow up. Solely discontinuation to prevent unintentional repetition of
                                    drugs was the first step of medication reconciliation. Safety message for doctor upon prescription of a drug item marked
                                    discontinued explicitly would be included in next phase of enhancement.

140
   63   64   65   66   67   68   69   70   71   72   73